Introducing the Ngaio Dx Point-of-Care Diagnostics Range
For more than 35 years, Ngaio Diagnostics has partnered with general practices, hospitals, laboratories and healthcare providers throughout New Zealand, supplying trusted diagnostic solutions that support quality patient care.
Focusing on our commitment to care driven by your needs, we are proud to introduce the Ngaio Dx range of rapid point-of-care diagnostics. Ngaio Dx brand brings together our decades of industry experience with high-performance rapid tests for NZ’s clinical healthcare environment.
Supporting Faster Clinical Decision-Making
Rapid point-of-care testing continues to play an increasingly important role in primary healthcare. Whether assessing patients presenting with sore throat or respiratory symptoms, clinicians need diagnostic tools that deliver reliable results quickly while fitting seamlessly into busy clinical workflows.
Ngaio Dx Strep A Rapid Test Cassette
Group A Streptococcal (Strep A) pharyngitis is a common presentation in primary care, particularly during the winter months. Accurate and timely diagnosis is especially important in NZ, where untreated Strep A infections remain associated with acute rheumatic fever in high-risk populations.
The Ngaio Dx Strep A Rapid Test Cassette is a qualitative lateral flow immunoassay for the detection of Group A Streptococcal antigens from throat swab specimens, providing results in just 5 minutes.
Key features include high clinical performance with internal procedural quality control.
- 95.1% sensitivity
- 97.8% specificity
- 97.1% overall accuracy
Designed for use alongside clinical assessment, the Ngaio Dx Strep A Rapid Test provides healthcare professionals with timely information to support patient management.
Ngaio Dx 4-in-1 Respiratory Antigen Test
Respiratory infections frequently present with similar clinical symptoms, making rapid differentiation an important part of patient assessment, particularly during periods of increased seasonal viral activity.
The Ngaio Dx 4-in-1 Respiratory Antigen Test is a professional-use lateral flow immunoassay that detects COVID-19, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) from a single nasal swab, providing results in approximately 15 minutes.
Key features include strong clinical performance with internal procedural quality control.
| Target | Sensitivity | Specificity | Overall Accuracy |
| SARS-CoV-2 (COVID-19) | 97.0% | 99.0% | 98.0% |
| Influenza A | 95.0% | 99.1% | 98.4% |
| Influenza B | 92.9% | 99.1% | 98.1% |
| Respiratory Syncytial Virus (RSV) | 94.3% | 96.2% | 95.9% |
By identifying four of the most common respiratory viruses from a single specimen, the Ngaio Dx 4-in-1 Respiratory Antigen Test provides clinicians with timely diagnostic information to support patient management, infection control measures and informed clinical decision-making.
Reliable Supply When It Matters Most
Healthcare providers need confidence not only in test performance but also in product availability. With 20 tests per box and up to 18-month expiry, Ngaio Dx rapid test kits are both convenient and competitively priced.
Ngaio Diagnostics understands the challenges of increased demand during winter respiratory seasons. By maintaining dependable local stock and responsive customer support, we help ensure our customers have access to the diagnostic products they need when they need them.
Whether you’re looking to expand your point-of-care testing capabilities or review your current rapid testing solutions, Ngaio Diagnostics is here to help.
Contact our team to request pricing, product information, or an evaluation of the Ngaio Dx Strep A Rapid Test Cassette or Ngaio Dx 4-in-1 Respiratory Antigen Test at info@ngaio.co.nz.